PRIA, Government Policy, Made Personal

Summary

The Institute Director can give grants or cooperative agreements to public or private nonprofit groups to help pay to plan, set up, improve, and run centers that do basic and clinical cancer research, train health workers, and demonstrate better ways to diagnose, prevent, control, and treat cancer. These awards must follow NIH rules and be made after the Institute’s advisory council is consulted. Federal money can be used for construction, staff and operating costs (including patient care needed for research), clinical and allied‑health training, continuing education and public information, and demonstration work. Support is for up to five years and can be renewed in five‑year steps if a peer review group reviews the center and recommends renewal. These centers may not be treated as "centers of excellence" under the separate law.

Title 42, §285a–3

The Public Health and Welfare, Source: USLM XML via OLRC

(a)(1)The Director of the Institute may enter into cooperative agreements with and make grants to public or private nonprofit entities to pay all or part of the cost of planning, establishing, or strengthening, and providing basic operating support for centers for basic and clinical research into, training in, and demonstration of advanced diagnostic, prevention, control, and treatment methods for cancer.

(2)A cooperative agreement or grant under paragraph (1) shall be entered into in accordance with policies established by the Director of NIH and after consultation with the Institute’s advisory council.

(b)Federal payments made under a cooperative agreement or grant under subsection (a) may be used for—

(1)construction (notwithstanding any limitation under section 289e of this title);

(2)staffing and other basic operating costs, including such patient care costs as are required for research;

(3)clinical training, including training for allied health professionals, continuing education for health professionals and allied health professions personnel, and information programs for the public respecting cancer; and

(4)demonstration purposes.

(c)Support of a center under subsection (a) may be for a period of not to exceed five years. Such period may be extended by the Director for additional periods of not more than five years each if the operations of such center have been reviewed by an appropriate technical and scientific peer review group established by the Director and if such group has recommended to the Director that such period should be extended.

(d)Research centers under this section may not be considered centers of excellence for purposes of section 282(b)(10) of this title.

Notes & Related Subsidiaries

Editorial Notes

Amendments

2007—Subsec. (d). Pub. L. 109–482 added subsec. (d). 2002—Subsec. (b). Pub. L. 107–206 substituted “Ruth L. Kirschstein National Research Service Awards” for “National Research Service Awards” in concluding provisions. 1988—Subsec. (a)(1). Pub. L. 100–607 inserted “control,” after “prevention,”.

Statutory Notes and Related Subsidiaries

Effective Date

of 2007 AmendmentAmendment by Pub. L. 109–482 applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see section 109 of Pub. L. 109–482, set out as a note under section 281 of this title.

§285a–3 National Cancer Research and Demonstration Centers